| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.033 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |